Effect of zinc supplementation on serum homocysteine in type 2 diabetic patients with microalbuminuria

Review of Diabetic Studies

Volumn 6, Issue 1, 2009, Pages 38-44

  Heidarian, Esfandiar ^a   Amini, Massoud ^a   Parham, Mahmoud ^a   Aminorroaya, Ashraf ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiovascular; Diabetes; Folate; Homocysteine; Microalbuminuria; Trace element; Vitamin B12; Zinc

Indexed keywords

ALBUMIN; CREATININE; CYANOCOBALAMIN; FOLIC ACID; GLUCOSE; HEMOGLOBIN A1C; HOMOCYSTEINE; LIPID; PLACEBO; ZINC;

AMINO ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; VITAMIN SUPPLEMENTATION;

EID: 67649360285     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2009.6.38     Document Type: Article

References (54)

1. Kazi TG, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalbani N, Kandhro GA. Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res 2008.122:1-18.
2. Anderson RA, Roussel AM, Zouari N, Mahjoub S, Matheau JM, Kerkeni A. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr 2001. 20:212-218. (Pubitemid 32606167)
3. Walter RM Jr, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield JW, Keen CL. Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care 1991.14:1050-1056.
4. Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 2006. 20:3-18.
5. Hambidge KM, Casey CE, Kerbs NF. Zinc. In: Mertz W (editor). Trace elements in human and animal nutrition. 5th ed., Academic Press, New York, 1986, p. 1-10.
6. Cunningham JJ, Fu A, Mearkle PL, Brown RG. Hyperzincuria in individuals with insulin-dependent diabetes mellitus: concurrent zinc status and the effect of high-dose zinc supplementation. Metabolism 1994. 43:1558-1562. (Pubitemid 24382708)
7. Chen MD, Liou SJ, Lin PY, Yang VC, Alexander PS, Lin WH. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice. Biol Trace Elem Res 1998.61:303-311. (Pubitemid 28145273)
8. Simon SF, Taylor CG. Dietary zinc supplementation attenuates hyperglycemia in db/db mice. Exp Biol Med (Maywood) 2001. 226(1):43-51. (Pubitemid 32048473)
9. Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 1991.10:339-352. (Pubitemid 121003905)
10. Ruiz C, Alegria A, Barbera R, Farre R, Lagarda J. Selenium, zinc and copper in plasma of patients with type 1 diabetes mellitus in different metabolic control states. J Trace Elem Med Biol 1998.12:91-95. (Pubitemid 28380236)
11. Ding W, Chai Z, Duan P, Feng W, Qian Q. Serum and urine chromium concentrations in elderly diabetics. Biol Trace Elem Res 1998. 63:231-237. (Pubitemid 28533355)
12. O'Brien SF, Powrie JK, Watts GF. Comparison of urinary albumin, retinol-binding protein and N-acetyl betaglucosaminidase as predictors of progression of low level albuminuria in diabetes. Ann Clin Biochem 1997. 34(Pt 2):202-204. (Pubitemid 27121046)
13. Parham M, Amini M, Aminorroaya A, Heidarian E. Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: a double blind, randomized, placebocontrolled, cross-over trial. Rev Diabet Stud 2008. 5:102-109.
14. Ng KC, Yong QW, Chan SP, Cheng A. Homocysteine, folate and vitamin B12 as risk factors for acute myocardial infarction in a Southeast Asian population. Ann Acad Med Singapore 2002. 31:636-640.
15. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, Hirschman GH, Myers BD. Development and progression of renal disease in Pima Indians with non-insulindependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med 1996. 335(22):1636-1642. (Pubitemid 26392728)
16. Wollesen F, Brattstrom L, Refsum H, Ueland PM, Berglund L, Berne C. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int 1999. 55:1028-1035. (Pubitemid 29100715)
17. Bostom AG, Kronenberg F, Jacques PF, Kuen E, Ritz E, König P, Kraatz G, Lhotta K, Mann JFE, Muller GA, et al. Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate. Atherosclerosis 2001. 159:219-223. (Pubitemid 33016638)
18. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998. 338:1042-1050.
19. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJ, Jakobs C, Bouter LM, Heine RJ, Stehouwer CD. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 1998. 18:133-138. (Pubitemid 28047610)
20. Hoogeveen EK, Kostense PJ, Jakobs C, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study. Circulation 2000. 101:1506-1511. (Pubitemid 30180885)
21. Okada E, Oida K, Tada H, Asazuma K, Eguchi K, Tohda G, Kosaka S, Takahashi S, Miyamori I. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 1999. 22:484-490. (Pubitemid 29106909)
22. Stehouwer CD, Gall MA, Hougaard P, Jakobs C, Parving HH. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria. Kidney Int 1999. 55:308-314. (Pubitemid 29004264)
23. Wotherspoon F, Laight DW, Browne DL, Turner C, Meeking DR, Allard SE, Munday LJ, Shaw KM, Cummings MH. Plasma homocysteine, oxidative stress and endothelial function in patients with type 1 diabetes mellitus and microalbuminuria. Diabet Med 2006. 23:1350-1356. (Pubitemid 44787800)
24. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995. 274:1049-1057.
25. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999. 131:363-375. (Pubitemid 29424631)
26. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997. 277:1775-1781.
27. de Bree A, Verschuren WM, Blom HJ, Kromhout D. Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20-65 y. Am J Clin Nutr 2001. 73:1027-1033. (Pubitemid 32496940)
28. Mason JB, Miller JW. The effects of vitamins B12, B6, and folate on blood homocysteine levels. Ann N Y Acad Sci 1992. 669:197-203.
29. Finkelstein JD. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 1998. 157(Suppl 2):S40-S44. (Pubitemid 28231872)
30. Fonseca VA, Mudaliar S, Schmidt B, Fink LM, Kern PA, Henry RR. Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects. Metabolism 1998. 47:686-689. (Pubitemid 28265172)
31. Finkelstein JD, Martin JJ. Methionine metabolism in mammals. Distribution of homocysteine between competing pathways. J Biol Chem 1984. 259:9508-9513. (Pubitemid 14060511)
32. Castro C, Millian NS, Garrow TA. Liver betainehomocysteine S-methyltransferase activity undergoes a redox switch at the active site zinc. Arch Biochem Biophys 2008. 472:26-33.
33. Evans JC, Huddler DP, Jiracek J, Castro C, Millian NS, Garrow TA, Ludwig ML. Betaine-homocysteine methyltransferase: zinc in a distorted barrel. Structure 2002. 10:1159-1171. (Pubitemid 35254005)
34. Millian NS, Garrow TA. Human betaine-homocysteine methyltransferase is a zinc metalloenzyme. Arch Biochem Biophys 1998. 356:93-98. (Pubitemid 28364359)
35. Zargar AH, Bashir MI, Masoodi SR, Laway BA, Wani AI, Khan AR, Dar FA. Copper, zinc and magnesium levels in type-1 diabetes mellitus. Saudi Med J 2002. 23(5):539-542. (Pubitemid 34624922)
36. Chen MD, Lin PY, Tsou CT, Wang JJ, Lin WH. Selected metals status in patients with noninsulin-dependent diabetes mellitus. Biol Trace Elem Res 1995. 50:119-124.
37. Fischer PW, Giroux A, L'Abbe MR. Effect of zinc supplementation on copper status in adult man. Am J Clin Nutr 1984. 40:743-746. (Pubitemid 14014406)
38. Soinio M, Marniemi J, Laakso M, Lehto S, Ronnemaa T. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Ann Intern Med 2004. 140:94-100. (Pubitemid 38095404)
39. Zago MP, Oteiza PI. The antioxidant properties of zinc: interactions with iron and antioxidants. Free Radic Biol Med 2001. 31:266-274. (Pubitemid 32607594)
40. Roussel AM, Kerkeni A, Zouari N, Mahjoub S, Matheau JM, Anderson RA. Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr 2003. 22:316-321. (Pubitemid 36927768)
41. Faure P, Benhamou PY, Perard A, Halimi S, Roussel AM. Lipid peroxidation in insulin-dependent diabetic patients with early retina degenerative lesions: effects of an oral zinc supplementation. Eur J Clin Nutr 1995. 49:282-288.
42. Ervin RB, Kennedy-Stephenson J. Mineral intakes of elderly adult supplement and non-supplement users in the third national health and nutrition examination survey. J Nutr 2002. 132:3422-3427. (Pubitemid 35314476)
43. Buysschaert M, Dramais AS, Wallemacq PE, Hermans MP. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care 2000. 23:1816-1822.
44. Looker HC, Fagot-Campagna A, Gunter EW, Pfeiffer CM, Narayan KM, Knowler WC, Hanson RL. Homocysteine as a risk factor for nephropathy and retinopathy in type 2 diabetes. Diabetologia 2003. 46:766-772. (Pubitemid 36831404)
45. Becker A, Kostense PJ, Bos G, Heine RJ, Dekker JM, Nijpels G, Bouter LM, Stehouwer CD. Hyperhomocysteinaemia is associated with coronary events in type 2 diabetes. J Intern Med 2003. 253:293-300. (Pubitemid 36315200)
46. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, D'Agostino RB Sr, Wilson PW. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001. 24:1403-1410. (Pubitemid 33716428)
47. Jager A, Kostense PJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Donker AJ, Stehouwer CD. Serum homocysteine levels are associated with the development of (micro) albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol 2001. 21:74-81. (Pubitemid 32061930)
48. Matthews RG, Goulding CW. Enzyme-catalyzed methyl transfers to thiols: the role of zinc. Curr Opin Chem Biol 1997. 1:332-339. (Pubitemid 127437159)
49. Vanuzzo D, Pilotto L, Lombardi R, Lazzerini G, Carluccio M, Diviacco S, Quadrifoglio F, Danek G, Gregori D, Fioretti P, et al. Both vitamin B6 and total homocysteine plasma levels predict long-term atherothrombotic events in healthy subjects. Eur Heart J 2007. 28:484-491. (Pubitemid 47343559)
50. Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994. 124:1927-1933. (Pubitemid 24334627)
51. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, Wright JD, Johnson CL. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999. 131:331-339.
52. Bloomgarden ZT. Consequences of diabetes: cardiovascular disease. Diabetes Care 2004. 27:1825-1831. (Pubitemid 38857469)
53. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997. 337:230-236. (Pubitemid 27310438)
54. Pavia C, Ferrer I, Valls C, Artuch R, Colome C, Vilaseca MA. Total homocysteine in patients with type 1 diabetes. Diabetes Care 2000. 23:84-87. (Pubitemid 30022900)